Amgen 8-K
Shareholder vote
Shareholders rejected an independent board chairman requirement and re-elected all director nominees.
Filed 2026-05-20 16:59 ET
- 5.07 Shareholder Vote Results
Summary
Annual meeting shareholder vote: all 12 director nominees were elected to one-year terms, executive compensation was approved, and Ernst & Young LLP was ratified as auditor for FY2026. The proposal to require an independent board chairman was not approved.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3